FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 01:15:49 29/06/2024 am IST | ||
| 4.05 EUR | -0.25% |
|
| Current month | -9.80% | ||
| 1 month | -15.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 4.05 | -0.25% |
| 27/24/27 | 4.06 | +1.25% |
| 26/24/26 | 4.01 | +8.09% |
| 25/24/25 | 3.71 | -3.13% |
| 24/24/24 | 3.83 | -9.46% |
Real-time BOERSE MUENCHEN
Last update June 29, 2024 at 01:15 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEG |
| ISIN | DE000HD2VEG8 |
| Date issued | 21/02/2024 |
| Strike | 392.1 $ |
| Maturity | Unlimited |
| Parity | 19.31 : 1 |
| Emission price | 10.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.73 € |
|---|---|
| Lowest since issue | 3.6 € |
| Spread | 0.01 € |
| Spread % | 0.25% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
